openPR Logo
Press release

Fungicides Market is Projected to Garner Significant Revenues by 2025

07-23-2021 11:16 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Markets and Markets

The fungicides market is estimated to account for a value of USD 18.7 billion in 2019 and is projected to grow at a CAGR of 4.6% from 2019, to reach a value of USD 24.5 billion by 2025. The global fungicides market is projected to witness significant growth due to factors such as the increase in demand for food security by the growing population, advancement in farming practices & techniques, and changing climatic conditions that favors disease occurrence. Fungicides are highly used for destroying harmful fungi affecting the crop yield. Thus, the need for fungicides to minimize crop loss is increasing across the world.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=356

By crop type, the cereals & grains segment is projected to be the fastest-growing segment in the fungicides market during the forecast period.

The growth in population and the consequent rise in demand for food materials have led to an increase in the need for crop protection chemicals, thereby increasing the demand for innovative fungicides solutions across regions. However, the demand for fungicides in various regions is projected to remain high due to the increasing number of crop types grown in abundance. For instance, the US is a leading producer of cereals and grains, while Europe is known for its wide-scale production of fruits and vegetables. The cereals & grains segment accounted for the largest market share in 2018, followed by the fruits & vegetable segment.

By type, the biological segment is projected to be the fastest-growing segment in the fungicides market during the forecast period.

Biological fungicides or biofungicides comprise beneficial microorganisms that are used to control fungal diseases. Many of these beneficial microorganisms are naturally found in the soil. Biofungicides are mostly used before the occurrence of disease. Their efficiency increases if used in combination with good agricultural practices. Biofungicides have different modes of action, such as competition/exclusion, antibiosis, parasitism, induced resistance, and plant growth promotion. Also, the over-use of chemical fungicides has harmful effects on the environment and thus, the fungicides market for biologicals is projected to grow at a higher CAGR from 2019 to 2025.

By form, the liquid segment is projected to dominate the fungicides market during the forecast period.

Liquid forms can be water-based, oil-based, polymer-based, or their combinations. Water-soluble liquids (SL) are liquid formulations based on technical material, which are insoluble in water and contain 36%–85% technical material and solvent. Water-based forms, such as suspension concentrates, suspo-emulsions, liquid concentrates, and capsule suspensions, require the addition of inert ingredients, which include stabilizers, stickers, surfactants, coloring agents, antifreeze compounds, suspending agents (such as bentone), and additional nutrients.

By mode of application, the post-harvest segment is projected to be the fastest-growing segment in the fungicides market during the forecast period.

Fungal infections contribute significantly to post-harvest losses in crops. The method is designed to reduce the amount of fungicides used and problems related to wastewater disposal. Fruits & vegetables are largely damaged after harvest by fungi and bacteria. Many chemicals are used as a spray or dip. Post-harvest fungicides are most frequently applied as aqueous suspensions.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=356

By mode of action, the systemic segment is projected to dominate the fungicides market during the forecast period.

Systemic fungicides are the most commonly used fungicides, as they tend to affect a single biochemical pathway within the pathogen, and hence, are called site-specific. On entry into the crop plant, they can move to a certain extent within the crop to the site of infection. Systemic fungicides can be used as protectants, eradicants, or both. Fungi may readily develop resistance to systemic fungicides, as they usually have a specific site of action in the target fungus.

Key players in this market include BASF SE (Germany), Bayer AG (Germany), Corteva, Inc. (US), Syngenta AG (Switzerland), FMC Corporation (US), and UPL Ltd. (India). These major players in this market are focusing on increasing their presence through expansions & investments, mergers & acquisitions, partnerships, joint ventures, and agreements. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities and strong distribution networks across these regions.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fungicides Market is Projected to Garner Significant Revenues by 2025 here

News-ID: 2335665 • Views:

More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analysis by 2028
Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624 These fertilizers are prized for their ability
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% from 2024 to 2029
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%. Download PDF Brochure:
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are